Early detection. Proactive intervention.

Edwards Oximetry Central Venous Catheter

ScvO2

70%

Edwards oximetry central venous catheter (CVC) — the first proven CVC with continuous ScvO

2 monitoring — reveals the true adequacy of

tissue oxygenation for clarity in early assessment and intervention.1–10

Edwards oximetry central venous catheter continuously monitors central venous oxygen saturation (ScvO2), an early indicator of compromised or inadequate oxygen delivery.6–10

By providing a more sensitive indicator of oxygen imbalance, Edwards oximetry central venous catheter identifies critical changes earlier than traditional vital signs and intermittent sampling—enabling you to recognize and prevent tissue hypoxia sooner.6–10

ECG

MAP

CVP

SpO2

ScvO2

0 Hour 1.5 Hours 3 Hours

Hemodynamic Trends

755025

100

1050

906030

15010090

ScvO2 = Early Warning and Prevention

Hemodynamic trends

Continuous ScvO2 monitoring: Proactive management of tissue hypoxia6–10

Helps guide therapy and provide real-time insight into the efficacy of intervention.6,7

Demonstrated prognostic value of continuous ScvO2 monitoring. 11

• Post-op high-risk surgeries12

• Trauma9

• Sepsis13

• Cardiac failure in congenital heart failure10

• Recovery in cardiac arrest14–15

Continuous ScvO2 monitoring has multiple applications in intra- and post-op stages: 16,17

• Risk for high blood loss, such as hepatic resections, trauma, vascular cases

• High fluid shifts in gastrointestinal cases

• Toleration of single-lung ventilation in thoracic procedures

• Early indication of failure to tolerate extubation

This graph has been created based on the cited studies

Continuous ScvO2 monitoring reveals the root cause of oxygen imbalance, allowing you to determine appropriate therapy.6,18

Edwards OximetryCentral Venous CatheterAccurate oxygenation status 2,4

Continuous ScvO2 monitoring, pressure monitoring and fl uid resuscitation

Simplicity and fl exibility — uses the same insertion techniques as central lines

Vasoactive medicationsInotropic medications

DysrhythmiaCongestive heart failure

Shock

COHemorrhage

Occult bleedingAnemia

Hemodilution

Hb

Hypoxia/hypoxemiaSuctioning, atelectasis

Ventilation/oxygenationLung disease

SaO2

SepsisWork of breathing

Fever, shiveringPain/anxiety

VO2

ScvO2

Convenient, accurate and easy to use.6,17,19

Edwards oximetry central venous catheter provides:

See advanced hemodynamic parameterswith a new level of clarity.*

The HemoSphere advanced monitor from Edwards Lifesciences reimagines the way you see, experience and interact with hemodynamic parameters. A range of clinical-support screen choices provides a new level of visual clinical support, facilitating decision making during rapidly changing situations.

*Compared to Vigilance II monitor

References inserted above

For professional use. See instructions for use for full prescribing information, including indications, contraindications, warnings, precautions and adverse events.

Edwards Lifesciences devices placed on the European market meeting the essential requirements referred to in Article 3 of the Medical Device Directive 93/42/EEC bear the CE marking of conformity.

Edwards, Edwards Lifesciences, the stylized E logo, EV1000, HemoSphere, PediaSat, Vigilance and Vigilance II are trademarks of Edwards Lifesciences Corporation or its affi liates. All other trademarks are the property of their respective owners.

© 2017 Edwards Lifesciences Corporation. All rights reserved. E6970/04-17/CC

Edwards Lifesciences • Route de l’Etraz 70, 1260 Nyon, Switzerland • edwards.com

See clearly. Stay ahead. Designed for use with Edwards’ monitoring platforms, Edwards’ oximetry central venous catheters off er the clarity of an early warning to support early intervention.

PediaSat Oximetry Catheter

The fi rst and only pediatric oximetry catheter with continuous ScvO2 monitoring to help you stay ahead of hypoxia and stages of sepsis.20–22

Edwards HemoSphereAdvanced Monitoring Platform

Adaptable module design allowsa broad range of working environments and applications.Screen options communicatepatient status at a glance.

PediaSat Edwards EV1000Clinical Platform

Presents patient physiologic status in an intuitive, meaningful way to clinically support proactive hemodynamic management.

Edwards oximetry central venous catheter

Lumens Length (CM)

X3820SP 3 20

X3820ST 3 20

For over 40 years, Edwards Lifesciences has been helping you make proactive clinical decisions to advance the care of surgical and critical care patients.

Through ongoing collaboration with you, ongoing education and our never-ending quest for advancement, Edwards develops solutions that provide the clarity to make proactive clinical decisions.

Know more. Visit Edwards.com/OximetryCVC

References for Edwards oximetry central venous catheter brochure

For professional use. See instructions for use for full prescribing information, including indications, contraindications, warnings, precautions and adverse events.

Edwards Lifesciences devices placed on the European market meeting the essential requirements referred to in Article 3 of the Medical Device Directive 93/42/EEC bear the CE marking of conformity.

Edwards, Edwards Lifesciences, the stylized E logo, PediaSat, and PreSep are trademarks of Edwards Lifesciences Corporation or its affiliates. All other trademarks are the property of their respective owners.

© 2017 Edwards Lifesciences Corporation. All rights reserved. E6970/04-17/CC

Edwards Lifesciences • Route de l’Etraz 70, 1260 Nyon, Switzerland • edwards.com

1. Edwards Oximetry Central Venous Catheter Instructions for Use

2. Clinical PreSep PediaSat Clinical Evaluation Report.

3. FDA 510k K053609

4. FDA 510k K061585

5. FDA 510k K091786

6. Reinhart K, et al. Continuous central venous and pulmonary artery oxygen saturation monitoring in the critically ill. Intensive Care Med. 2004;30(8):1572-8.

7. Rivers EP, et al. Central venous oxygen saturation monitoring in the critically ill patient. Curr Opin Crit Care. 2001;7(3):204-11.

8. Ingelmo P, et al. Importance of monitoring in high risk surgical patients. Minerva Anestesiol. 2002;68(4):226-30.

9. Scalea, TM, et al. Central venous oxygen saturation: a useful clinical tool in trauma patients. J Trauma 1990;30(12):1539-43.

10. Ander, DS, et al. Undetected cardiogenic shock in patients with congestive heart failure presenting to the emergency department. Am J Cardiol 1998;82(7):888-91.

11. Spenceley, N., et al. Continuous central venous saturations during pericardial tamponade case report. Pediatr Crit Care Med 2007,Vol. 8,No. 3,p18.2.153.

12. Pearse, R, et al. Changes in central venous saturation after major surgery, and association with outcome. Crit Care 2005;9(6):R694-91.

13. Rady, MY, et al. Resuscitation of the critically ill in the ED: responses of blood pressure, heart rate, shock index, central venous oxygen saturation, and lactate. Am J Emerg Med 1996;14(2):218-25.

14. Rivers, EP, et al. The clinical implications of continuous central venous oxygen saturation during human CPR. Ann Emerg Med 1992;21(9):1094-101.

15. Nakazawa, K, et al. Usefulness of central venous oxygen saturation monitoring during cardiopulmonary resuscitation. A comparative case study with end-tidal carbon dioxide monitoring. Intensive Care Med 1994;20(6):450-1.

16. Noguiera P, et al. Central Venous Saturation: A Prognostic Tool in Cardiac Surgery Patients. J Intensive Care Med. 2010;25(2):111-116.

17. Vallet B, et al. Venous oxygen saturation as a physiologic transfusion trigger. Crit Care. 2010;14:213.

18. Zaja J. Venous oximetry. Signa Vitae 2007;2(1):6-10.

19. Mahajan A, et al. An experimental and clinical evaluation of a novel central venous catheter with integrated oximetry for pediatric patients undergoing cardiac surgery. Pediatric Central Venous Oximetry. Anest Anal. 2007;Vol.105, No. 6, 1598.

20. Krahn, G., et al. Early clinical evaluation of the Edwards PediaSat™ oximetry catheter in pediatric patients. Pediatr Crit Care Med 2007,Vol. 8,No. 3,p18.2.152.

21. Spenceley, N., et al. Continuous central venous saturation monitoring in pediatrics: a case report. Pediatr Crit Care Med 2008, Vol. 9, No. 2, p e13-e16.

22. Lemson et al. Advanced hemodynamic monitoring in critically ill patients. Pediatrics. 2011.